Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma

SIMPLE SUMMARY: Monoclonal antibodies represent a major therapeutic progress in multiple myeloma during the last decade. The use of antibodies as well as antibody drug conjugates has changed the treatment landscape rapidly. The intent of this paper is to summarize the current major results of monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Radocha, Jakub, van de Donk, Niels W. C. J., Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037134/
https://www.ncbi.nlm.nih.gov/pubmed/33805481
http://dx.doi.org/10.3390/cancers13071571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037134/
https://www.ncbi.nlm.nih.gov/pubmed/33805481
http://dx.doi.org/10.3390/cancers13071571

Ejemplares similares